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http://dx.doi.org/10.1016/j.jfma.201Madelung’s disease (multiple symmetric lipomatosis) is a rare disease characterized by
abnormal diffuse lipomatosis in proximal upper limbs and neck. Previous reports have shown
that this disease is associated with alcoholism, polyneuropathy, mitochondrial disease, and
glucose intolerance. Here, we describe a 46-year-old man having Madelung’s disease associ-
ated with polyneuropathy and symptomatic hypokalemia. He presented with insidious-onset
weakness and numbness in lower limbs for 7 years and recent deterioration of symptoms. Prox-
imal weakness improved with potassium supplement. Our observation may extend the pheno-
type of Madelung’s disease to hypokalemic periodic paralysis.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Madelung’s disease, also called multiple symmetric lip-
omatosis (MSL), is a rare disease and characterized by
abnormal diffuse lipomas located in the neck, shoulder, and
inguinal areas. Patients often seek medical help for
cosmetic reason. Most of the patients are alcoholic.1e3
There are occasional associations with polyneuropathy,
mitochondrial disease, and glucose intolerance.4e6 The
pathophysiology of MSL is uncertain, but defect in lipolytic
pathway and mitochondrial defect are reported.1,4,6,7t of Neurology, En Chu Kong
.
.com.tw (C.-H. Lin).
ight ª 2012, Elsevier Taiwan LLC
2.07.019Here, we present a case of MSL with multiple neurological
manifestations.
Case report
A 46-year-old man presented with a history of alcoholism
for 10 years (about 500e800 mL of 40% alcohol beverage per
day). Insidious onset of mild distal predominant numbness
and weakness on the four limbs were noted about 7 years
ago, without affecting his daily life very much in the initial
years. Although he had a habit of alcohol consumption, he
claimed to have regular diet every day. He found
symmetric, gradually enlarging, painless soft mass devel-
oping around his neck, shoulders, proximal upper limbs,
and inguinal areas since 4 years ago. He had even asked for
help in a local hospital, but no definite diagnosis was made& Formosan Medical Association. All rights reserved.
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days before admission. He visited our outpatient clinic for
progressive worsening of proximal weakness since the last 3
days before admission, which made him unable to climb
stairs without assistance. He needed to perform some
warm-up exercise for getting up from squatting position. He
did not have a large amount of carbohydrate intake or
exercise recently. There was no urinary retention, but
erectile dysfunction was noted in recent months. Physical
examination revealed normal blood pressure (120/
90 mmHg) and normal body temperature (36.5C). Multiple
painless, movable masses, without margin, erythematous
change, or induration, were seen around neck, shoulder,
and proximal upper limbs (Fig. 1). Neurological examination
showed proximal weakness with increased knee jerk on the
lower limb and abdominal rectus without pathological
reflex. Ascending hypesthesia and reduced vibration
sensation from toes up to knee were noted.
Laboratory work-up showed anemia with upper limit
mean corpuscular volume (MCV: 95.5 fL; Hb: 11.4 g/dL),
hypokalemia (2.5 meq/L), reduced folic acid level (5.17 ng/
mL), normal thyroid function test (T3: 93.95 ng/dL; TSH
2.0491 mIU/L), and normal Vit B12 level (189 ng/mL).
Further work-up for hypokalemia, including transtubular
potassium gradient 2.57 (normal <3), urine potassium
7.4 mEq/L (normal <20 mEq/L), and urine chloride
148 mEq/L (normal >20 mEq/L), indicated that there was
no renal loss of potassium. Muscle enzyme, lipid profile,
and renal function were all within normal limit. Electro-
physiological study showed sensorimotor polyneuropathy
with mild slowing of motor nerve conduction velocity.
Sympathetic skin response and ReR interval variation test
were performed for suspected autonomic dysfunction, but
the results were within normal limit. Electromyography
showed no myopathic change. Somatosensory evoked
potential showed prolonged central conduction time and
suggested possible cervical myelopathy, but spine MRI
showed mild cervical stenosis without significant cord
compression. Neck CT showed diffuse lipomatosis around
neck and upper back along both muscular and fascia planes,Figure 1 Photograph of a patient, showing lipoma around
the neck, shoulders, and arms (arrows).which is different from the findings in common obesity
(Fig. 2). Carotid duplex study showed no significant stenosis
on the extracranial cervical arteries. Study on the mito-
chondrial gene mutation (MERRF, myoclonic epilepsy with
ragged red fibers, A8344G) was negative. Besides, we
arranged a prolonged exercise test, which induced the
decrease of compound motor action potential on the
femoral nerve. Proximal weakness improved with potassium
supplements. Considering his proximal weakness with
warm-up phenomenon, hypokalemia with the positive
result of prolonged exercise,8 and good response to potas-
sium supplement, periodic paralysis is possible. He possibly
also had mild cervical myelopathy, as suggested by
increased deep tendon reflex of lower limbs and prolonged
central conduction time on somatosensory evoked potential
despite no significant cord compression on MRI. Folic acid
deficiency-related myelopathy was also considered. Based
on his multiple lipomatosis, and neck CT reports in combi-
nation with the aforementioned examinations, we diag-
nosed this case as Madelung’s disease (MSL) with mild
sensorimotor polyneuropathy, myelopathy, and possible
periodic paralysis.Discussion
MSL is a rare syndrome of large confluent symmetric
lipomas around the neck, shoulder, or trunk. Benjamine
Brodie first described this disease in St George hospital in
1846.4 In addition to Madelung’s disease and MSL, it was
also named as LaunoiseBensaude syndrome.5 By perform-
ing a literature review using PubMed, only about 250 cases
were found to be reported since 1954 to 2009. It is more
common in the Mediterranean region, and its incidence was
reported as 1/25,000 in Italian population.9 Only a few
cases were reported in Asia.1,10 The diagnosis of MSL is
based on a “sight diagnosis” by demonstrating multiple,
symmetric fatty accumulations typically distribution in the
neck and proximal upper trunk; the rest of body does not
show much fatty accumulations. This distribution is
different from that in case of simple obesity, which
generally has fat tissues on the four limbs and trunk.
Besides, image of fatty accumulations shows that the fatty
bulk in MSL is noncapsulated and distributed along vascular
and muscular planes, in contrast with lipoma, which is
capsulated in subcutaneous space. Most patients are asso-
ciated with alcoholism, but the casual effect between
alcohol and MSL is unknown.1,2,4,5 Alcoholism-related
macrocytic anemia and elevated liver enzyme are noted.
Axonal predominant polyneuropathy and autonomic
dysfunction are common neurological complications.1,3e5,11
Whether all the aforementioned neurological manifesta-
tions are directly related to MSL or they are the results of
alcoholism still remains controversial. In some reports,
occurrence of polyneuropathy was attributed to chronic
alcohol consumption.4 Occasional comorbidity associated
with diabetes mellitus, hyperuricemia, hyper-
alphalipoproteinemia, and thyroid disorder was reported.1
Etiology of this disease is still unclear. At first, an
abnormal lipolytic process in response to catecholamine-
inducing lipid mobilization was proposed.1,4 Recently, there
were serial reports suggesting the relationship between MSL
Figure 2 Neck MRI showing fat tissue distribution around the cervical and thoracic spine and shoulder inside the muscular and
vascular planes (arrows).
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patients.6,7,12,13 However, these patients with both lipolytic
and mitochondrial diseases had additional symptoms sug-
gesting mitochondrial cytopathy, such as ataxia, myoc-
lonus, myopathy, or neuropathy, which were not shown in
other reports on MSL. Furthermore, no mitochondrial
disorder was reported in several studies of familial MSL.14,15
Our patient had no mutation of MERRF or other sign of
mitochondrial disease. It suggested the heterogeneity of
different pathogenesis process in MSL.
Treatment is indicated mainly for cosmetic reason,
including liposuction and direct lipoectomy. In rare cases
with lipomatosis extending to mediastinum and tracheal
compression, tracheostomy was needed.3 Diet control with
low intake of fat could not arrest the progression of lip-
omatosis.16 Abstinence from alcohol may reduce or even
stop the progression of lipomatosis.3 Enzi et al followed up
31 MSL patients for 4e26 years, with mortality being as high
as 25%. Out of the eight patients who died, nearly half
(three patients) had sudden death and all had autonomic
neuropathy and no coronary heart disease.3 Overall, long-
term follow-up reports are still limited.
In past decades, only two patients with MSL were re-
ported in Taiwan, who had no polyneuropathy or other
neurologic symptom.10 We presented a case of MSL associ-
ated with alcoholism, polyneuropathy, symptomatic hypo-
kalemia, and possible myelopathy. His past history of long-
term alcohol consumption and evidence of polyneuropathy
are the same to previous reported comorbidity. In addition,
our patient presented with symptoms of hypokalemic
periodic paralysis, which was not due to thyroid disease or
poor dietary intake. However, overactivation of hypothal-
amicepituitaryeadrenal axis in alcoholism can also cause
hypertensive hypokalemia,17 which was not the case in our
patient (extrarenal loss of potassium). This is the first
report of a case with a possible comorbidity of hypokalemic
periodic paralysis in MSL patients.
Conclusion
Our case report may extend the phenotype of MSL with
symptomatic hypokalemia. MSL patients with episodicattack of paralysis need further care in medical
management.References
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